Huntington disease

Last updated: May 20, 2023

Huntington disease

MASTER FM EOR

MASTER FM EOR

Aortic valve disease
Mitral valve disease
Pulmonary valve disease
Tricuspid valve disease
Lung cancer
Sleep apnea
Diarrhea: Clinical
Rotavirus
Norovirus
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Vibrio cholerae (Cholera)
Ventricular septal defect
Hypertrophic cardiomyopathy
Shigella
Gastroenteritis
Ulcerative colitis
Crohn disease
Hyperlipidemia
Heart failure
Chronic bronchitis
Irritable bowel syndrome
Emphysema
Aphthous ulcers
Meniere disease
Dizziness and vertigo: Clinical
Parotitis
Acute cholecystitis
Chronic cholecystitis
Gallstones
Gallstone ileus
Colorectal polyps
Colorectal cancer
Labyrinthitis
Breast cancer
Cervical cancer
Conjunctivitis
Diabetic retinopathy
Hypertensive emergency
Fibromyalgia
Gastritis
Skin cancer
Contact dermatitis
Atopic dermatitis
Seborrhoeic dermatitis
Human herpesvirus 8 (Kaposi sarcoma)
Eczematous rashes: Clinical
Lichen planus
Menopause
Spinal disc herniation
Lower back pain: Clinical
Bursitis
Osteoporosis
Age-related macular degeneration
Reactive arthritis
Stevens-Johnson syndrome
Hemorrhoid
Peptic ulcer
Mallory-Weiss syndrome
Gastrointestinal bleeding: Clinical
Diverticulosis and diverticulitis
Boerhaave syndrome
Anal fissure
Esophageal cancer
Esophagitis: Clinical
Portal hypertension
Pregnancy
Contraception: Clinical
Otitis media
Otitis externa
Poststreptococcal glomerulonephritis
Membranoproliferative glomerulonephritis
Alport syndrome
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Testicular cancer
Membranous nephropathy
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Rosacea
Psoriasis
Erythema multiforme
Sleep disorders: Clinical
Peripheral artery disease
Peripheral vascular disease: Clinical
Mycobacterium tuberculosis (Tuberculosis)
Cirrhosis
Cushing syndrome
Primary adrenal insufficiency
Retinal detachment
Sialadenitis
Eye conditions: Retinal disorders: Pathology review
Acute pancreatitis
Chronic pancreatitis
Actinic keratosis
Bullous pemphigoid
Alopecia: Clinical
Abnormal uterine bleeding: Clinical
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus
Benign prostatic hyperplasia
Epididymitis
Prostatitis
Neisseria gonorrhoeae
Chlamydia trachomatis
Urethritis
Erysipelas
Parvovirus B19
Measles virus
Human herpesvirus 6 (Roseola)
Pediatric infectious rashes: Clinical
Iron deficiency anemia
Anemia of chronic disease
Aplastic anemia
Folate (Vitamin B9) deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Vitamin B12 deficiency
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Atrial flutter
Atrioventricular block
Bundle branch block
Premature atrial contraction
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Wolff-Parkinson-White syndrome
Gastroesophageal reflux disease (GERD)
Vulvovaginitis: Clinical
Pelvic inflammatory disease
Acne vulgaris
Cellulitis
Folliculitis
Pressure ulcer
Gardnerella vaginalis (Bacterial vaginosis)
Candida
Trichomonas vaginalis
Impetigo
Human papillomavirus
Bites and stings: Clinical
Angina pectoris
Stable angina
Unstable angina
Prinzmetal angina
Coronary artery disease: Clinical
Hypertension: Clinical
Allergic rhinitis
Glaucoma
Streptococcus pyogenes (Group A Strep)
Borrelia burgdorferi (Lyme disease)
Asthma
Gout
Nasal polyps
Pneumonia
Pneumonia: Clinical
Bowel obstruction
Bowel obstruction: Clinical
Volvulus
Intussusception
Retropharyngeal and peritonsillar abscesses
Hordeolum (stye)
Osteoarthritis
Rheumatoid arthritis
Rheumatoid arthritis: Clinical
Sarcoptes scabiei (Scabies)
Alzheimer disease
Vascular dementia
Frontotemporal dementia
Parkinson disease
Dementia with Lewy bodies
Huntington disease
Headaches: Clinical
Migraine
Cluster headache
Tension headache
Bell palsy
Orthostatic hypotension
Hyperthyroidism
Seizures: Clinical
Seizures and epilepsy
Transient ischemic attack
Delirium
Dementia and delirium: Clinical
Onychomycosis
Pityriasis rosea
Vertigo
Hypothyroidism
Pericarditis and pericardial effusion
Aortic dissection
Pulmonary embolism
Pulmonary hypertension
Myocarditis
Acute leukemia
Chronic leukemia
Von Willebrand disease
Hemophilia
HIV (AIDS)
Meningitis
Hodgkin lymphoma
Non-Hodgkin lymphoma
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Hemolytic-uremic syndrome
Polycythemia vera (NORD)
Hernias: Clinical
Abdominal hernias
Lower urinary tract infection
Orchitis
Acute pyelonephritis
Kidney stones
Appendicitis
Anorexia nervosa
Generalized anxiety disorder
Panic disorder
Anxiety disorders: Clinical
Bipolar and related disorders
Bulimia nervosa
Major depressive disorder
Child abuse: Clinical
Alcohol use disorder
Cannabis use disorder
Opioid use disorder
Cocaine use disorder
Tobacco use disorder
Anaphylaxis
Burns
Burns: Clinical
Bites and stings: Clinical
Orbital cellulitis
Acute respiratory distress syndrome
Placental abruption
Placenta previa
Hypertension
Pneumothorax
Pneumothorax: Clinical
Post-traumatic stress disorder
Phobias
Neuroleptic malignant syndrome
Factor V Leiden
Protein C deficiency
Protein S deficiency
Salmonellosis
Syncope: Clinical

Transcript

Watch video only

Huntington disease, or HD, is a rare neurodegenerative disease that involves a repeated sequence of DNA that causes an abnormal protein to form, leading to abnormal movements and cognitive problems.

Huntington disease is an autosomal dominant genetic disorder, which means that one affected copy of a gene is enough to cause disease. Affected people are typically present in each generation, because an affected person (male or female) has a 50% chance of passing on the affected gene to a child, which causes that child to have the disease.

In most people, a gene called huntingtin or HTT on chromosome 4, contains a triplet repeat, where the nucleotides C, A, and G are repeated 10-35 times in a row. In people with Huntington disease, this repeat goes on for 36 or more times in a row. CAG codes for the amino acid glutamine, so people with Huntington disease patients will have 36 or more glutamines in a row in the huntingtin protein. So, in addition to being a triplet repeat disorder, HD is, more specifically, a “polyglutamine” disease.

The specific way in which extra glutamines cause HD symptoms isn’t fully worked out, but some clues are that the mutated protein aggregates within the neuronal cells of the caudate and putamen of the basal ganglia causing neuronal cell death. Cell death might be related to excitotoxicity – which is excessive signaling of these neurons, which leads to high intracellular calcium.

The expanded CAG repeats not only affect the huntingtin protein – they affect DNA replication itself. When copying the HTT gene, DNA polymerase can basically lose track of which CAG it’s on and accidently add extra CAGs. Since as a zygote develops into a fetus and eventually into a full adult, by the time sperm and eggs are created, several dozen cell divisions, each with a round of DNA replication have taken place, and so there have already been ample opportunities for repeat expansion, and the more repeats that’re added, the more unstable it gets.

This expansion of the originally inherited gene means a child of a parent with HD can inherit even more CAG repeats than the parent did. The higher the number of repeats in the protein, the earlier the age when a person starts having symptoms. This phenomenon is called anticipation, which means that Huntington disease families often show earlier symptom onset with each generation. Even repeats of 27-35 CAGs can expand occasionally; these are called “pre-mutation” alleles, since they don’t cause the disease, but they’re set-up for developing a mutation of 36 or more CAGs.

This process of adding more repeats is called repeat expansion and it happens way more in the production of sperm than of eggs, so both anticipation and new disease alleles generally happens when the father is the affected parent. When a person has 40+ repeats, they show 100% penetrance and they will have the disease. For reasons that remain unknown, people with 36-39 repeats can show reduced penetrance; some may have symptoms while others may not. Because of this penetrance, the test for HD, which counts the number of CAG repeats, is really good at determining whether HD will develop in an at-risk individual.